Here’s What Medical Cannabis Looks Like in Texas

Compassionate Cultivation founder and CEO Morris Denton looks over marijuana plants in the company’s flowering room in Manchaca, Texas.

Nearly all forms of cannabis are illegal in Texas. And by illegal, I mean very illegal. Possession of a small amount of cannabis concentrate—what we in the legal states know as a $30 vape cartridge—is a felony in the Lone Star State.

Medical marijuana here has almost no THC. It’s actually lower in THC than hemp-derived CBD.
But there is one form of cannabis that is allowed. It’s a highly specialized cannabidiol oil that contains, by law, no more than 0.5% THC and no less than 10% CBD. It’s available only to patients with intractable epilepsy, and three companies are licensed to produce and distribute it.

No Brainer: CBD & THC for Head Injuries

brain-1024x576

  • According to a U.S. government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”
  • A 2014 study found that traumatic brain injury (TBI) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana.
  • Preclinical research and anecdotal accounts indicate that CBD is highly active against brain ischemia, modulating many of the molecular hallmarks of TBI pathology.
  • CBD normalizes post-ischemic heart arrhythmia and limits the size of damaged brain tissue in mice when administered shortly before or after a closed head injury.
  • CBD produces no intoxicating effects, no THC-like high, and its use does not lead to tolerance.
  • As yet there have been no FDA-approved clinical trials to determine the efficacy of CBD-rich cannabis oil extracts for traumatic brain injury.

Texas lawmaker whose bill allowed medical cannabis oil wants to expand its use in 2019

skliGov. Greg Abbott displays SB339 as Rep. John Zerwas, Rep. Stephanie Klick and Sen. Kevin Eltife watch. The bill would allow limited use of medical marijuana oil that will control seizures in epileptic children.

Four years after she authored legislation that legalized the sale of medical cannabis oil to Texans suffering from a small number of conditions, Republican state Rep. Stephanie Klick plans to push to expand the list of eligible patients in 2019.

On Thursday, the Fort Worth representative filed House Bill 3703, which would give Texans with multiple sclerosis, epilepsy and spasticity access to medical cannabis oil containing low levels of tetrahydrocannabinol, the psychoactive element in marijuana known as THC.

Continue reading “Texas lawmaker whose bill allowed medical cannabis oil wants to expand its use in 2019”

The 10 Terp Commandments: How to Preserve the Aroma of Your Cannabis

terps

We’re living in heady times. Cannabis products are rapidly advancing. Connoisseur-level appreciation for them is flourishing.

But look around you and you’ll still see people unknowingly wasting their precious time and hard-earned money, throwing perfectly good cannabis terpenes to the wind. Don’t make the mistake of sullying divine flavors with cheap plastic bags and resiny old pipes.

It’s time to emancipate yourself from mental slavery. Here are ten terpene preservation commandments—guidelines to help you identify, preserve, and appreciate your bud’s flavorful potential.

Continue reading “The 10 Terp Commandments: How to Preserve the Aroma of Your Cannabis”

First Clinical Trial Of Cannabis For PTSD in Veterans Is Now Complete

cli

After a decade of working on the first FDA-approved trial examining the effects of THC and CBD on the symptoms of PTSD in war veterans, a team of researchers has declared their clinical trial complete. The process, however, was not simple.

“We are proud to have persevered through these regulatory hurdles independently of hospitals, universities, or the VA system,” commented site principal investigator Dr. Sue Sisley in a press release.

The Multidisciplinary Association for Psychedelic Studies (MAPS) received approval from the U.S. Public Health Service to start the study back in 2014. Research began in January 2017 at Phoenix, Arizona’s Scottsdale Research Institute, and was slated to also take place at Johns Hopkins University, until the school dropped out of the experiment in March 2017.

Continue reading “First Clinical Trial Of Cannabis For PTSD in Veterans Is Now Complete”

What Is Caryophyllene and What Does This Cannabis Terpene Do?

ben.png

Terpenes provide a wide variety of aromatic properties ranging from floral and earthy notes to musky and citrusy ones. When it come to the spicier side of the spectrum, caryophyllene holds the trophy for the most flair.

The terpene caryophyllene is present in many herbs and spices, including black pepper, basil, and oregano, and cannabis strains with high levels of it deliver a spicy, funky warmth to the nose, similar to cinnamon and cloves.

What makes caryophyllene an intriguing terpene is its relationship with our endocannabinoid system, particularly, its ability to bind to CB2 receptors. Because of this, it comes with a host of potential medical benefits.

Continue reading “What Is Caryophyllene and What Does This Cannabis Terpene Do?”

DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access

A sheet of cannabis marijuana in the defocus with the image of the formula CBD

The U.S. Drug Enforcement Administration has taken some cannabidiol out of the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.

It’s a decision that immediately affects CBD producers but also signals the agency’s first admission that the plant has medical value.

The DEA announced Thursday that drugs including CBD with THC content below 0.1% are now considered Schedule 5 drugs, as long as they have been approved by the U.S. Food and Drug Administration.

It is the first time the agency has lowered any type of cannabis from Schedule 1.

Continue reading “DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access”